Physician profile
Jerry Shen
NPI 1306283882
$5,234.66
in general payments reported to CMS, 2019-2025
37 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $151 · 2021: $604 · 2022: $879 · 2023: $1,283 · 2024: $1,106 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,433.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $792.66 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $582.65 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $441.09 | 2021-2025 | Jardiance |
| Abbvie INC. | $425.28 | 2021-2025 | Linzess, Ubrelvy |
| Novo Nordisk INC | $422.65 | 2019-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $377.49 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $290.00 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Amgen INC. | $283.49 | 2019-2025 | Repatha, Otezla, Evenity |
| Exact Sciences Corporation | $243.84 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $188.78 | 2020-2025 | Gardasil 9, Capvaxive, Gardasil |
| Sanofi-Aventis U.S. LLC | $154.31 | 2021-2024 | |
| Abbott Laboratories | $125.32 | 2022-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $122.05 | 2022-2024 | |
| Sanofi Pasteur INC. | $121.87 | 2019-2025 | |
| Amarin Pharma, INC. | $65.93 | 2019-2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.